Pierrot Harvie
About Pierrot Harvie
Pierrot Harvie is a Clinical Manufacturing Manager at Precision NanoSystems Inc. in Vancouver, Canada, with extensive experience in drug delivery systems and a strong academic background in microbiology and immunology.
Current Role at Precision NanoSystems
Pierrot Harvie serves as the Clinical Manufacturing Manager at Precision NanoSystems Inc. since 2020. In this role, he is responsible for overseeing clinical manufacturing processes and ensuring compliance with regulatory standards. His position is based in Vancouver, British Columbia, Canada, where he has contributed to the development of innovative solutions in the field of nanomedicine.
Previous Experience at PhaseRx
Prior to his current role, Pierrot Harvie worked at PhaseRx as Associate Director of Formulations from 2013 to 2017. During his four years in this position, he was involved in the formulation development of therapeutic products, contributing to the advancement of drug delivery systems. His tenure at PhaseRx took place in the Greater Seattle Area.
Educational Background in Microbiology
Pierrot Harvie has a robust educational background in microbiology. He earned a Bachelor of Science in Biologie medicale from Université du Québec à Trois-Rivières from 1985 to 1989. He furthered his studies at Université de Montréal, obtaining a Master of Science in microbiology from 1989 to 1991, followed by a Ph.D. in Microbiology/Immunology from Université Laval from 1992 to 1996.
Expertise in Drug Delivery Systems
Pierrot Harvie possesses extensive expertise in preclinical pharmacology and toxicity, particularly in evaluating drug delivery systems for anti-tumor activity. His proficiency includes virological and immunological techniques, as well as histopathology analysis related to disease progression. He has been involved in targeted mRNA delivery to the liver for intracellular enzyme replacement therapy.
Career in Research and Development
Throughout his career, Pierrot Harvie has held various research positions. He worked as a Senior Research Scientist at Marina Biotech, Inc. from 2008 to 2012, and as a Research Scientist at Targeted Genetics Corporation from 1999 to 2003. He also held roles at Nastech Pharmaceutical Company Inc., Celator Pharmaceuticals, and BC Cancer Agency, where he gained significant experience in drug development and GMP manufacturing regulations.